Regina M. Paglia - 06 Jul 2021 Form 4 Insider Report for Dicerna Pharmaceuticals Inc

Role
Chief Human Resources Officer
Signature
/s/ Douglas W. Pagan, attorney-in-fact
Issuer symbol
N/A
Transactions as of
06 Jul 2021
Net transactions value
-$52,018
Form type
4
Filing time
08 Jul 2021, 21:32:39 UTC
Previous filing
29 Jun 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DRNA Common Stock Options Exercise +1,450 +539% 1,719 06 Jul 2021 Direct F1
transaction DRNA Common Stock Options Exercise +1,712 +100% 3,431 06 Jul 2021 Direct F1
transaction DRNA Common Stock Tax liability $52,018 -1,404 -41% $37.05 2,027 06 Jul 2021 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DRNA Restricted Stock Units Options Exercise $0 -1,450 -17% $0.000000 7,250 06 Jul 2021 Common Stock 1,450 Direct F1, F3
transaction DRNA Restricted Stock Units Options Exercise $0 -1,712 -12% $0.000000 11,988 06 Jul 2021 Common Stock 1,712 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Regina M. Paglia is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents the contingent right to receive one share of the Issuer's Common Stock.
F2 Represents the number of shares of the Issuer's Common Stock withheld by the Issuer to cover tax withholding obligations in connection with the vesting of RSUs.
F3 The vesting schedule was amended such that 1,450 RSUs from the second vesting tranche vested on July 6, 2021 with the remainder of the RSUs being subject to the existing vesting terms of the underlying award agreement.
F4 The vesting schedule was amended such that 1,712 RSUs from the first vesting tranche vested on July 6, 2021 with the remainder of the RSUs being subject to the existing vesting terms of the underlying award agreement.